- $1.90bn
- $1.69bn
- $249.60m
Brief: LeMaitre Reports Q3 2021 Financial Results
LeMaitre Vascular Inc reports results for the quarter ended in September - Earnings Summary
LeMaitre Vascular Inc expected to post earnings of 33 cents a share - Earnings Preview
LeMaitre Vascular Inc reports results for the quarter ended in June - Earnings Summary
Brief: Lemaitre Q2 2021 Financial Results
LeMaitre Vascular Inc expected to post earnings of 34 cents a share - Earnings Preview
Brief: Lemaitre Announces Pricing Of Public Offering Of Common Stock
Brief: Lemaitre Vascular Inc - Q2 2021 Preliminary Net Sales Of $40.7Mm, Up 64% Reported, Up 35% Organic Versus Q2 2020
Brief: Lemaitre Vascular Inc - Intends To Use Net Proceeds From Offering To Repay In Full Borrowings Outstanding Under Its Senior Secured Credit Facility
LeMaitre Vascular Inc reports results for the quarter ended in March - Earnings Summary
Brief: Lemaitre Q1 2021 Financial Results
LeMaitre Vascular Inc expected to post earnings of 27 cents a share - Earnings Preview
Brief: LeMaitre Reports Q4 Earnings Per Share of $0.34
Brief: LeMaitre Vascular Announces Q3 2020 Financial Results
Brief: Lemaitre Vascular Acquires Artegraft For $90.0 Mln
Brief: Lemaitre Vascular Files For Mixed Shelf Of Upto $200 Mln
Brief: Lemaitre Vascular Committed To Plan For Reducing Expenses, Including Reduction In Force Of About 13% Of Workforce
Brief: Lemaitre Vascular Inc Withdraws Prior Annual Guidance For 2020
Brief: Lemaitre Vascular Inc - QTRLY Earnings Of $0.23 Per Diluted Share